Carrillo-Esper R, Carrillo-Córdova JR, Carrillo-Córdova LD, Carrillo-Córdova CA

Language: Spanish
References: 13
Page: 67-69
PDF size: 73.52 Kb.

ABSTRACT

In 1924, Libman and Sacks described valvular lesions in patients with lupus erythematosus. Libman-Sacks valvular lesions are sterile fibrinous vegetations that preferentially develop at the left-sided heart valves. Reports of their prevalence range from 53 to 74%. Libman-Sacks endocarditis is associated with disease activity and antiphospholipid antibodies titer. Echocardiography is a useful tool for documenting valvular involvement and dysfunction as well as disease progression. Transesophageal echocardiography is superior to transthoracic echocardiography in detecting Libman-Sacks endocarditis. This report describes the echocardiographic image of Libman-Sacks endocarditis in a patient with active lupus erithematosus.

REFERENCES

1. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924;33:701-707.

2. Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Volteas V, Moutsopoulos HM. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med 2007;120:636-642.

3. Roldan CA, Shivley BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996;335:1424-1430.

4. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996;93:1579-1587.

5. Chartash EK, Lans DM, Paget SA, Qamar T, Loscksmith MD. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med 1989;86:407-412.

6. Roldan CA. Diagnostic value of transesophageal echocardiography in Libman-Sacks endocarditis. Minerva Cardioangiol 2009;57:467-481.

7. Roldan CA, Qualls CR, Sopko KS, Sibbit WL Jr. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol 2008;35:224-229.

8. Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Revisiting Libman-Sacks endocarditis: a historical review and update. Clin Allergy Immunol 2009;36:126-130.

9. Roldan CA, Shively BK, Lau CC, Gurule FT, Smith FA, Crawford MH. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipids antibodies. J Am Coll Cardiol 1992;20:1127-1134.

10. Li JS, Sexton DJ, Mick N, Nettles R, Fowller VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633.

11. Ménard GE. Establishing the diagnosis of Libman-Sacks endocarditis in systemic lupus erythematosus. J Gen Intern Med 2008;23:883-886.

12. Brito FA, Tófani ML, Tófani FA, Kakehasi AM, Lanna CC, Carvalho MA. Libman-Sacks endocarditis and oral anticoagulation. Arq Bras Cardiol 2004;82:378-383.

13. Dandekar UP, Watkin R, Chandra N, Santo KC, Bhudia S, Pitt M, et al. Aortic valve replacement for Libman-Sacks endocarditis. Ann Thorac Surg 2009;88:669-671.